Genetic and genomic approaches to understanding macrophage identity and function

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 4, 2015, Pages 755-762

  Glass, Christopher K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

genetics; genomics; macrophages; on factors; transcripti

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 6; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSCRIPTION FACTOR;

B LYMPHOCYTE; BONE MARROW DERIVED MACROPHAGE; CYTOGENETICS; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMICS; HISTONE MODIFICATION; HUMAN; HUMAN GENOME; MACROPHAGE FUNCTION; MICROGLIA; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA ANALYSIS; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; GENOTYPE; MACROPHAGE; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOMICS; GENOTYPE; HUMANS; MACROPHAGES; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84933514813     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304051     Document Type: Review

References (36)

1. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656-661. doi: 10.1126/science.1178331.
2. Gordon S, Plüddemann A, Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev. 2014;262:36-55. doi: 10.1111/imr.12223.
3. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445-455. doi: 10.1038/ nature12034.
4. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, Bortoluci KR, Almeida SR, Herzenberg LA, Herzenberg LA. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A. 2010;107:2568-2573. doi: 10.1073/ pnas.0915000107.
5. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014;157:832-844. doi: 10.1016/j.cell.2014.04.016.
6. Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. Immunol Rev. 2014;262:153-166. doi: 10.1111/imr.12218.
7. Wang Z, Gerstein M, Snyder M. RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57-63. doi: 10.1038/nrg2484.
8. Morozova O, Marra MA. Applications of next-generation sequencing technologies in functional genomics. Genomics. 2008;92:255-264. doi: 10.1016/j.ygeno.2008.07.001.
9. Gosselin D, Link V, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK. Environmnent drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014;159:1-14.
10. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993;75:135-146.
11. Witmer-Pack MD, Hughes DA, Schuler G, Lawson L, McWilliam A, Inaba K, Steinman RM, Gordon S. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci. 1993;104(Pt 4):1021-1029.
12. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336:86-90. doi: 10.1126/ science.1219179.
13. Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, Kündig TM, Frei K, Ginhoux F, Merad M, Becher B. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 2012;37:1050-1060. doi: 10.1016/j.immuni.2012.11.001.
14. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, Barrow AD, Diamond MS, Colonna M. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol. 2012;13:753-760. doi: 10.1038/ni.2360.
15. Andersson R, Gebhard C, Miguel-Escalada I, et al; FANTOM Consortium. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455-461.
16. Levine M. Transcriptional enhancers in animal development and evolution. Curr Biol. 2010;20:R754-R763. doi: 10.1016/j.cub.2010.06.070.
17. Shlyueva D, Stampfel G, Stark A. Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet. 2014;15:272-286. doi: 10.1038/nrg3682.
18. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57-74.
19. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576-589. doi: 10.1016/j. molcel.2010.05.004.
20. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, Glass CK. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell. 2013;51:310-325. doi: 10.1016/j. molcel.2013.07.010.
21. Garber M, Yosef N, Goren A, et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell. 2012;47:810-822.
22. Mullen AC, Orlando DA, Newman JJ, Lovén J, Kumar RM, Bilodeau S, Reddy J, Guenther MG, DeKoter RP, Young RA. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell. 2011;147:565-576. doi: 10.1016/j.cell.2011.08.050.
23. Samstein RM, Arvey A, Josefowicz SZ, Peng X, Reynolds A, Sandstrom R, Neph S, Sabo P, Kim JM, Liao W, Li MO, Leslie C, Stamatoyannopoulos JA, Rudensky AY. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 2012;151:153-166. doi: 10.1016/j.cell.2012.06.053.
24. He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, Mieczkowski P, Lieb JD, Zhao K, Brown M, Liu XS. Nucleosome dynamics define transcriptional enhancers. Nat Genet. 2010;42:343-347. doi: 10.1038/ng.545.
25. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010;107:21931-21936. doi: 10.1073/pnas.1016071107.
26. Gautier EL, Shay T, Miller J, et al; Immunological Genome Consortium. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 2012;13:1118-1128.
27. Rosas M, Davies LC, Giles PJ, Liao CT, Kharfan B, Stone TC, O'Donnell VB, Fraser DJ, Jones SA, Taylor PR. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science. 2014;344:645-648. doi: 10.1126/science.1251414.
28. Butovsky O, Jedrychowski MP, Moore CS, et al. Identification of a unique tgf-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131-143.
29. Makwana M, Jones LL, Cuthill D, Heuer H, Bohatschek M, Hristova M, Friedrichsen S, Ormsby I, Bueringer D, Koppius A, Bauer K, Doetschman T, Raivich G. Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS. J Neurosci. 2007;27:11201-11213. doi: 10.1523/JNEUROSCI.2255-07.2007.
30. Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, Glass CK. Effect of natural genetic variation on enhancer selection and function. Nature. 2013;503:487-492. doi: 10.1038/nature12615.
31. Keane TM, Goodstadt L, Danecek P, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477:289-294.
32. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213-1218. doi: 10.1038/nmeth.2688.
33. Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, Keren-Shaul H, Mildner A, Winter D, Jung S, Friedman N, Amit I. Immunogenetics. Chromatin state dynamics during blood formation. Science. 2014;345:943-949. doi: 10.1126/science.1256271.
34. Li P, Spann NJ, Kaikkonen MU, et al. Ncor repression of lxrs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell. 2013;155:200-214.
35. Brown JD, Lin CY, Duan Q, et al. Nf-kappab directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56(2):219-231.
36. Hoeksema MA, Gijbels MJ, Van den Bossche J, et al. Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med. 2014;6:1124-1132.